Ritholtz Wealth Management Bio Rad Laboratories, Inc. Transaction History

Ritholtz Wealth Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$463.67 - $597.16 $247,599 - $318,883	-534 Reduced 56.03%	419 $207,000
Q1 2022 Apr 14, 2022	SELL	$524.57 - $735.42 $69,243 - $97,075	-132 Reduced 12.17%	953 $537,000
Q4 2021 Jan 18, 2022	SELL	$708.84 - $794.68 $4,961 - $5,562	-7 Reduced 0.64%	1,085 $820,000
Q3 2021 Oct 14, 2021	SELL	$657.71 - $825.77 $94,052 - $118,085	-143 Reduced 11.58%	1,092 $815,000
Q2 2021 Jul 20, 2021	SELL	$576.64 - $649.04 $44,977 - $50,625	-78 Reduced 5.94%	1,235 $796,000
Q1 2021 May 12, 2021	SELL	$547.01 - $662.35 $96,273 - $116,573	-176 Reduced 11.82%	1,313 $750,000
Q4 2020 Jan 19, 2021	BUY	$510.68 - $643.45 $59,749 - $75,283	117 Added 8.53%	1,489 $868,000
Q3 2020 Oct 23, 2020	BUY	$454.43 - $535.6 $338,095 - $398,486	744 Added 118.47%	1,372 $707,000
Q2 2020 Jul 15, 2020	BUY	$334.87 - $493.06 $210,298 - $309,641	628 New	628 $284,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Ritholtz Wealth Management with notifications on news.